Vor Biopharma Ownership | Who Owns Vor Biopharma?

Vor Biopharma Ownership Summary

Vor Biopharma is owned by 22.66% institutional investors, 4.29% insiders, and 73.06% retail investors. Tcg crossover management is the largest institutional shareholder, holding 57.47% of VOR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.10% of its assets in Vor Biopharma shares.

VOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vor Biopharma	22.66%	4.29%	73.06%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tcg crossover management	5.67M	57.47%	$96.50M
Ra capital management	5.40M	54.75%	$96.43M
Fcpm iii services b.v.	4.12M	41.71%	$73.45M
Vr adviser	3.04M	30.81%	$54.26M
Frazier life sciences management	2.54M	25.77%	$45.38M
Caligan partners lp	1.93M	19.50%	$34.34M
Paradigm biocapital advisors lp	1.75M	17.73%	$31.22M
Great point partners	1.75M	17.73%	$31.22M
Fmr	1.54M	15.60%	$27.47M
Marshall wace, llp	1.15M	11.68%	$20.57M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fcpm iii services b.v.	4.12M	10.17%	$73.45M
Great point partners	1.75M	7.18%	$31.22M
Rosalind advisors	700.00K	5.02%	$12.49M
Propel bio management	314.54K	3.52%	$5.59M
Tcg crossover management	5.67M	2.76%	$96.50M
Caligan partners lp	1.93M	2.29%	$34.34M
Vr adviser	3.04M	2.03%	$54.26M
Frazier life sciences management	2.54M	1.17%	$45.38M
Ra capital management	5.40M	1.02%	$96.43M
Sphera funds management	321.92K	0.91%	$5.74M

Top Buyers

Holder	Shares	% Assets	Change
Tcg crossover management	5.67M	2.76%	5.67M
Marshall wace, llp	1.15M	0.02%	1.15M
Vr adviser	3.04M	2.03%	1.10M
State street	1.12M	0.00%	1.03M
Caligan partners lp	1.93M	2.29%	1000.00K

Top Sellers

Holder	Shares	% Assets	Change
5am venture management	-	-	-6.36M
Blackrock	497.70K	-	-1.75M
Woodline partners lp	-	-	-1.11M
Artal group	-	-	-1.00M
Fmr	1.54M	0.00%	-986.50K

New Positions

Holder	Shares	% Assets	Change	Value
Tcg crossover management	5.67M	2.76%	5.67M	$96.50M
Marshall wace, llp	1.15M	0.02%	1.15M	$20.57M
Rosalind advisors	700.00K	5.02%	700.00K	$12.49M
Boothbay fund management	555.70K	0.13%	555.70K	$9.91M
Braidwell lp	466.77K	0.28%	466.77K	$8.33M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Point72 (difc)	-26.00
Nisa investment advisors	-45.00
Smartleaf asset management	-102.00
Caitong asset management	-110.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	19	-68.85%	2,236,902	-91.24%	22	0.02%	16	-60.00%	1	-85.71%
Dec 31, 2025	32	-30.43%	6,076,499	61.43%	90	2.87%	20	17.65%	3	-86.96%
Sep 30, 2025	45	9.76%	3,764,067	-93.40%	56	2.72%	17	-10.53%	22	100.00%
Jun 30, 2025	41	-2.38%	57,027,241	7.15%	45	2.50%	21	16.67%	11	-35.29%
Mar 31, 2025	44	-16.98%	60,090,600	-1.40%	48	0.61%	18	-10.00%	18	12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.12M	3.10%	-
Fidelity Select Biotechnology	1.54M	2.83%	-
Vanguard Total Stock Mkt Idx Inv	1.07M	1.97%	-
State Street® SPDR® S&P® Biotech ETF	1.06M	1.96%	-10.47K
Fidelity Growth Compy Commingled Pl S	1.96M	1.57%	-207.80K
Vanguard US Total Market Shares ETF	1.39M	1.11%	-
Fidelity Growth Company Fund	1.27M	1.02%	-140.15K
Vanguard Institutional Extnd Mkt Idx Tr	335.38K	0.62%	1.66K
Fidelity Capital Appreciation	610.40K	0.49%	-
Fidelity VIP Growth Initial	618.39K	0.49%	-

Recent Insider Transactions

Date	Name	Activity	Value
Apr 22, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$2.60M
Apr 17, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$7.46M
Apr 20, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$2.71M
Apr 14, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$2.46M
Apr 13, 2026	RA CAPITAL MANAGEMENT, L.P.	Sell	$8.57M

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	15
2026 Q1	-	-
2025 Q4	-	56
2025 Q3	-	14
2025 Q2	-	-

VOR Ownership FAQ

Who Owns Vor Biopharma?

Vor Biopharma shareholders are primarily institutional investors at 22.66%, followed by 4.29% insiders and 73.05% retail investors. The average institutional ownership in Vor Biopharma's industry, Biotech Stocks , is 35.75%, which Vor Biopharma falls below.

Who owns the most shares of Vor Biopharma?

Vor Biopharma’s largest shareholders are Tcg crossover management (5.67M shares, 57.47%), Ra capital management (5.4M shares, 54.75%), and Fcpm iii services b.v. (4.12M shares, 41.71%). Together, they hold 153.93% of Vor Biopharma’s total shares outstanding.

Does Blackrock own Vor Biopharma?

BlackRock is not among the top 10 institutional shareholders of Vor Biopharma.

Who is Vor Biopharma’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Vor Biopharma’s biggest shareholder by percentage of total assets invested, with 10.17% of its assets in 4.12M Vor Biopharma shares, valued at 73.45M$.

Who is the top mutual fund holder of Vor Biopharma shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Vor Biopharma shares, with 3.10% of its total shares outstanding invested in 2.12M Vor Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools